HomeAbout

TL;DR CNBC


Pfizer's drug for advanced lung cancer shows promising long-term trial results - TL;DR CNBC

Pfizer's drug for advanced lung cancer shows promising long-term trial results

Publishing timestamp: 2024-05-31 13:46:15


Summary

Pfizer's drug for advanced lung cancer showed promising long-term results in a late-stage trial, potentially establishing it as a new standard treatment. The drug, Lorbrena, helped patients live longer without cancer progression, with most experiencing benefits for over five years. The data will be presented at the American Society of Clinical Oncology's annual meeting in Chicago.


Sentiment: POSITIVE

Tickers: PFE

Keywords: business newspfizer incbiotech and pharmaceuticalsbreaking newssciencebiotechnologypharmaceuticalshealth care industrybusiness

Source: https://www.cnbc.com/2024/05/31/pfizer-lung-cancer-drug-shows-promising-long-term-trial-results.html


Developed by Leo Phan